These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2918505)

  • 1. Synthesis and hypertensive activity of neuropeptide Y fragments and analogues with modified N- or C-termini or D-substitutions.
    Boublik JH; Scott NA; Brown MR; Rivier JE
    J Med Chem; 1989 Mar; 32(3):597-601. PubMed ID: 2918505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated, branched, and/or cyclic analogues of neuropeptide Y: importance of the pancreatic peptide fold in the design of specific Y2 receptor ligands.
    Reymond MT; Delmas L; Koerber SC; Brown MR; Rivier JE
    J Med Chem; 1992 Oct; 35(20):3653-9. PubMed ID: 1433176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
    Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
    Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for neuropeptide Y18-36-evoked hypotension: a systematic study.
    Feinstein RD; Boublik JH; Kirby D; Spicer MA; Craig AG; Malewicz K; Scott NA; Brown MR; Rivier JE
    J Med Chem; 1992 Jul; 35(15):2836-43. PubMed ID: 1379641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents.
    Shen GH; Grundemar L; Zukowska-Grojec Z; Håkanson R; Wahlestedt C
    Eur J Pharmacol; 1991 Nov; 204(3):249-56. PubMed ID: 1723049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, structure, and antagonistic properties of des-Asn29[D-Trp28,32]NPY(27-36).
    Balasubramaniam A; Zhai W; Tao Z; Huang Y; Fischer JE; Eden P; Taylor JE; Kar L; Samarasinghe SD; Johnson ME
    Peptides; 1996; 17(7):1113-8. PubMed ID: 8959744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells.
    Grundemar L; Håkanson R
    Br J Pharmacol; 1991 Dec; 104(4):776-8. PubMed ID: 1725763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous NPY (27-36)-D decreases cardiac output in conscious Sprague-Dawley rats.
    Roscoe AK; Nyce J; Wooles WR
    Peptides; 1996; 17(3):539-43. PubMed ID: 8735985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY.
    Clark JT; Sahu A; Kalra PS; Balasubramaniam A; Kalra SP
    Regul Pept; 1987 Jan; 17(1):31-9. PubMed ID: 3562905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining structural requirements for neuropeptide Y receptors using truncated and conformationally restricted analogues.
    Kirby DA; Koerber SC; Craig AG; Feinstein RD; Delmas L; Brown MR; Rivier JE
    J Med Chem; 1993 Feb; 36(3):385-93. PubMed ID: 8426366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
    Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
    J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased NPY activity in the PVN contributes to food-restriction induced reductions in blood pressure in aortic coarctation hypertensive rats.
    VanNess JM; DeMaria JE; Overton JM
    Brain Res; 1999 Mar; 821(2):263-9. PubMed ID: 10064812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions.
    Kirby DA; Boublik JH; Rivier JE
    J Med Chem; 1993 Nov; 36(24):3802-8. PubMed ID: 8254609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
    Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
    Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues.
    Cross LJ; Beck-Sickinger AG; Bienert M; Gaida W; Jung G; Krause E; Ennis M
    Br J Pharmacol; 1996 Jan; 117(2):325-32. PubMed ID: 8789386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [D-TRP32]neuropeptide Y: a competitive antagonist of NPY in rat hypothalamus.
    Balasubramaniam A; Sheriff S; Johnson ME; Prabhakaran M; Huang Y; Fischer JE; Chance WT
    J Med Chem; 1994 Mar; 37(6):811-5. PubMed ID: 8145232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinction of NPY receptors in vitro and in vivo. I. NPY-(18-36) discriminates NPY receptor subtypes in vitro.
    Michel MC; Schlicker E; Fink K; Boublik JH; Göthert M; Willette RN; Daly RN; Hieble JP; Rivier JE; Motulsky HJ
    Am J Physiol; 1990 Jul; 259(1 Pt 1):E131-9. PubMed ID: 2164786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and neuropeptide Y18-36. Structural and biological characterization.
    Boublik J; Scott N; Taulane J; Goodman M; Brown M; Rivier J
    Int J Pept Protein Res; 1989 Jan; 33(1):11-5. PubMed ID: 2722395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.